The Leicester Cancer Research Centre

The University established a Department of Cancer Studies in 2003 following the restructuring of 30 Departments within the Medical School. The Department transitioned to a Research Centre in September 2017 as part of a restructuring exercise

The current Director is Professor Catrin Pritchard.

Cancer Studies has excellent laboratory and clinical facilities at Leicester Royal Infirmary and Leicester General Hospital.  It also has laboratory facilities in the Henry Welcome Building on the main University campus.  

Most cancer patients are diagnosed and managed in a modern purpose built cancer centre (the Osborne Building) on the Leicester Royal Infirmary site.  The centre contains operating theatres, a large chemotherapy suite, a modern radiotherapy unit and a clinical trials facility that runs both academic and commercial trials. 

The centre also hosts the Children’s Cancer and Leukaemia Group (CCLG), a leading children’s cancer charity and the UK and Ireland’s professional association for those involved in the treatment and care of children and teenagers with cancer. CCLG Over the last 40 years, CCLG has played a key role in the major improvements in survival rates and the standards of care for children. We bring together childhood cancer professionals to ensure all children receive the best possible treatment and care.

There are still some childhood cancers with a poor outlook, and many treatments can have long-lasting side effects. Further research is therefore vital, and the ultimate aim of CCLG is to cure as many children as possible while reducing the short and long-term side effects of treatment. They fund and support research into childhood cancers, and help young patients and their families with expert, high quality and award-winning information resources.

The centre is also host to the East Midlands Forensic Pathology Unit, which is based in the Robert Kilpatrick Building at the Leicester Royal Infirmary site.

Share this page:

NEWS

Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform

---------------------------------

SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.